Antisense DNA and RNA: Potential therapeutics for viral infection

Ji Yuan, Travis Lim, Zhen Liu, Dexin Qiu, Brian Wong, Honglin Luo, Xiaoning Si, Bruce McManus, Decheng Yang

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Antisense DNA and RNA are valuable tools to inhibit expression of a target gene in a sequence-specific manner. These molecules are not only widely used for gene functional study but also for therapeutic purpose. The strategy for therapeutics is attributed to its specific inhibition of gene expression of pathogens or disease-causing genes. Three types of anti-mRNA strategies can be distinguished, including antisense oligodeoxynucleotide (AODN), nucleic acid enzymes, and double-stranded small interfering RNA (siRNA). In this article we overview the basic principles of AODN and siRNA and then focus on their potential applications in antiviral therapy including our own data on coxsackieviral infection, a common pathogen of human myocarditis. In addition, we also briefly discuss the problems and difficulties in these drug developments, which need to be overcome to achieve the final goal in clinical application.

Original languageEnglish (US)
Pages (from-to)367-377
Number of pages11
JournalAnti-Infective Agents in Medicinal Chemistry
Volume5
Issue number4
DOIs
StatePublished - Oct 1 2006

Fingerprint

Antisense DNA
Antisense RNA
Virus Diseases
Oligodeoxyribonucleotides
Small Interfering RNA
Genes
Double-Stranded RNA
Myocarditis
Nucleic Acids
Antiviral Agents
Therapeutics
Gene Expression
Messenger RNA
Enzymes
Infection
Pharmaceutical Preparations

Keywords

  • Antisense
  • Antiviral agents
  • Coxsackievirus B3
  • Oligodeoxynucleotide
  • Small interfering RNA

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases

Cite this

Antisense DNA and RNA : Potential therapeutics for viral infection. / Yuan, Ji; Lim, Travis; Liu, Zhen; Qiu, Dexin; Wong, Brian; Luo, Honglin; Si, Xiaoning; McManus, Bruce; Yang, Decheng.

In: Anti-Infective Agents in Medicinal Chemistry, Vol. 5, No. 4, 01.10.2006, p. 367-377.

Research output: Contribution to journalReview article

Yuan, J, Lim, T, Liu, Z, Qiu, D, Wong, B, Luo, H, Si, X, McManus, B & Yang, D 2006, 'Antisense DNA and RNA: Potential therapeutics for viral infection', Anti-Infective Agents in Medicinal Chemistry, vol. 5, no. 4, pp. 367-377. https://doi.org/10.2174/187152106778520460
Yuan, Ji ; Lim, Travis ; Liu, Zhen ; Qiu, Dexin ; Wong, Brian ; Luo, Honglin ; Si, Xiaoning ; McManus, Bruce ; Yang, Decheng. / Antisense DNA and RNA : Potential therapeutics for viral infection. In: Anti-Infective Agents in Medicinal Chemistry. 2006 ; Vol. 5, No. 4. pp. 367-377.
@article{3c491ad1142346369548a5a707ecb9a6,
title = "Antisense DNA and RNA: Potential therapeutics for viral infection",
abstract = "Antisense DNA and RNA are valuable tools to inhibit expression of a target gene in a sequence-specific manner. These molecules are not only widely used for gene functional study but also for therapeutic purpose. The strategy for therapeutics is attributed to its specific inhibition of gene expression of pathogens or disease-causing genes. Three types of anti-mRNA strategies can be distinguished, including antisense oligodeoxynucleotide (AODN), nucleic acid enzymes, and double-stranded small interfering RNA (siRNA). In this article we overview the basic principles of AODN and siRNA and then focus on their potential applications in antiviral therapy including our own data on coxsackieviral infection, a common pathogen of human myocarditis. In addition, we also briefly discuss the problems and difficulties in these drug developments, which need to be overcome to achieve the final goal in clinical application.",
keywords = "Antisense, Antiviral agents, Coxsackievirus B3, Oligodeoxynucleotide, Small interfering RNA",
author = "Ji Yuan and Travis Lim and Zhen Liu and Dexin Qiu and Brian Wong and Honglin Luo and Xiaoning Si and Bruce McManus and Decheng Yang",
year = "2006",
month = "10",
day = "1",
doi = "10.2174/187152106778520460",
language = "English (US)",
volume = "5",
pages = "367--377",
journal = "Anti-Infective Agents",
issn = "2211-3525",
publisher = "Bentham Science Publishers",
number = "4",

}

TY - JOUR

T1 - Antisense DNA and RNA

T2 - Potential therapeutics for viral infection

AU - Yuan, Ji

AU - Lim, Travis

AU - Liu, Zhen

AU - Qiu, Dexin

AU - Wong, Brian

AU - Luo, Honglin

AU - Si, Xiaoning

AU - McManus, Bruce

AU - Yang, Decheng

PY - 2006/10/1

Y1 - 2006/10/1

N2 - Antisense DNA and RNA are valuable tools to inhibit expression of a target gene in a sequence-specific manner. These molecules are not only widely used for gene functional study but also for therapeutic purpose. The strategy for therapeutics is attributed to its specific inhibition of gene expression of pathogens or disease-causing genes. Three types of anti-mRNA strategies can be distinguished, including antisense oligodeoxynucleotide (AODN), nucleic acid enzymes, and double-stranded small interfering RNA (siRNA). In this article we overview the basic principles of AODN and siRNA and then focus on their potential applications in antiviral therapy including our own data on coxsackieviral infection, a common pathogen of human myocarditis. In addition, we also briefly discuss the problems and difficulties in these drug developments, which need to be overcome to achieve the final goal in clinical application.

AB - Antisense DNA and RNA are valuable tools to inhibit expression of a target gene in a sequence-specific manner. These molecules are not only widely used for gene functional study but also for therapeutic purpose. The strategy for therapeutics is attributed to its specific inhibition of gene expression of pathogens or disease-causing genes. Three types of anti-mRNA strategies can be distinguished, including antisense oligodeoxynucleotide (AODN), nucleic acid enzymes, and double-stranded small interfering RNA (siRNA). In this article we overview the basic principles of AODN and siRNA and then focus on their potential applications in antiviral therapy including our own data on coxsackieviral infection, a common pathogen of human myocarditis. In addition, we also briefly discuss the problems and difficulties in these drug developments, which need to be overcome to achieve the final goal in clinical application.

KW - Antisense

KW - Antiviral agents

KW - Coxsackievirus B3

KW - Oligodeoxynucleotide

KW - Small interfering RNA

UR - http://www.scopus.com/inward/record.url?scp=33750091940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750091940&partnerID=8YFLogxK

U2 - 10.2174/187152106778520460

DO - 10.2174/187152106778520460

M3 - Review article

AN - SCOPUS:33750091940

VL - 5

SP - 367

EP - 377

JO - Anti-Infective Agents

JF - Anti-Infective Agents

SN - 2211-3525

IS - 4

ER -